Podcast | Practice of Medicine | October 25, 2021
Nephrology for the Non-Nephrologist: Hypertension
Hypertension is a leading cause of kidney disease and in part four of this multipart podcast series, Dr. Benjamin Broome, a nephrologist with Nephrology Associates in Birmingham, Alabama, is joined by Dr. Donald DiPette, who serves on faculty in the department of internal medicine at the University of South Carolina in Columbia to discuss the clinical implications of hypertension as a significant cardiovascular risk factor. They will also review the clinical care implications of the recent hypertension management and treatment guidelines.
At the conclusion of this activity, the attendee should be able to:
- Understand the clinical implications of hypertension as a significant cardiovascular risk factor and its target organ damage.
- Review and determine the clinical care practice implications of the newer hypertension management and treatment guidelines.
- Determine the definition of “resistant hypertension” and some of the common causes of resistant hypertension at the primary care level.
Subscribe: iTunes, Spotify, YouTube, Stitcher Radio, iHeartRadio
Benjamin Broome, MD
Dr. Benjamin Broome grew up in Savannah, Georgia. After high school he attended the University of Georgia where he was a member of the honors program and graduated Magna Cum Laude with a degree in Nutrition Science. He received a medical degree from the Medical College of Georgia. Dr. Broome then completed his Internal Medicine training with Baptist Health Systems in Birmingham prior to attending Vanderbilt University for his Nephrology fellowship. Dr. Broome is certified by the American Board of Internal Medicine, a member of the American Society of Nephrology and the Renal Physicians Association.
Donald DiPette, MD, FACP, FAHA
Dr. DiPette is the Health Sciences Distinguished Professor and previous Dean of the University of South Carolina School of Medicine in Columbia, South Carolina.
References and Resources
- World Health Organization. Guideline for the pharmacological treatment of hypertension in adults. 2021. https://apps.who.int/iris/bitstream/handle/10665/344424/9789240033986-eng.pdf.
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065.
- 2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). https://academic.oup.com/eurheartj/article/39/33/3021/5079119.
- National Kidney Foundation